81.9 AE 11.5 mmHg; baseline 24-hour urine protein was 1.7 AE 2.2 gram; baseline serum creatinine was 108.9 AE 60.1 umol/l. 44 patients had microhaematuria. 46 of the 50 patients with IgA nephropathy were treated with ACEI/ ARB therapy. 25 out of the 46 patients were given additional steroid therapy and 8 out of the 25 received a second immunosuppressive agent in the light of the clinicopathological pictures. The changes in proteinuria and serum creatinine level at 6 months and 12 months will be reported. Conclusion: The high prevalence of IgA nephropathy in our biopsy population was similar to reports from other regions of mainland China. Besides ACEI and ARB, steroid and additional immunosuppressant are important therapies for selected patients with biopsy-proven IgA nephropathy. Objective: Urinary sediment miRNAs have a lot of advantages, such as noninvasive, simple and easy to get. They may become a new direction of searching non-invasive biomarkers of IgAN. Methods: A total 93 IgAN patients, 40 primary glomerulonephritis (non-IgAN) patients and 92 healthy controls of urinary sediment were collected. Total miRNAs were extracted and analyzed by miRNA microarray. Urine erythrocytes were separated by CD235a magnetic bead and microvesicles were collected by ultracentrifugation to detect differential miRNAs sources. Results: Comparing IgAN group with normal control group, we found 214 miRNAs were significantly different by using miRNA chips. By using quantitative PCR, we confirmed that urinary sediment miR-25, miR-144 and miR-486 in IgAN group were significantly higher than these in normal group and disease control group. ROC curve analysis showed these three miRNAs had good specificity and sensitivity for the diagnosis of IgAN, in which the AUC value of miR-486 was the largest and reaching 0.935 (Table 1) . By using CD235a immunomagnetic technology, we confirmed miR-25, miR-144 and miR-486 were mainly derived from urinary erythrocytes. Moreover, the increased of miRNAs expression levels in IgAN patients were associated with erythrocytes passing through IgAN lesions renal glomerulus. When peripheral blood erythrocytes were compressed when exiting an impaired nephron, they could secrete some miRNA-containing microparticles.
Objective: Urinary sediment miRNAs have a lot of advantages, such as noninvasive, simple and easy to get. They may become a new direction of searching non-invasive biomarkers of IgAN. Methods: A total 93 IgAN patients, 40 primary glomerulonephritis (non-IgAN) patients and 92 healthy controls of urinary sediment were collected. Total miRNAs were extracted and analyzed by miRNA microarray. Urine erythrocytes were separated by CD235a magnetic bead and microvesicles were collected by ultracentrifugation to detect differential miRNAs sources. Results: Comparing IgAN group with normal control group, we found 214 miRNAs were significantly different by using miRNA chips. By using quantitative PCR, we confirmed that urinary sediment miR-25, miR-144 and miR-486 in IgAN group were significantly higher than these in normal group and disease control group. ROC curve analysis showed these three miRNAs had good specificity and sensitivity for the diagnosis of IgAN, in which the AUC value of miR-486 was the largest and reaching 0.935 (Table 1) . By using CD235a immunomagnetic technology, we confirmed miR-25, miR-144 and miR-486 were mainly derived from urinary erythrocytes. Moreover, the increased of miRNAs expression levels in IgAN patients were associated with erythrocytes passing through IgAN lesions renal glomerulus. When peripheral blood erythrocytes were compressed when exiting an impaired nephron, they could secrete some miRNA-containing microparticles.
Conclusion: Urinary sediment miR-25, miR-144 and miR-486 were good noninvasive diagnosis biomarkers of IgA nephropathy. They were mainly derived from erythrocytes. The increase of miRNA expression levels of urinary erythrocytes was associated with erythrocytes passing through IgAN lesions renal glomerulus. And they may have some biological effects on renal inherent cells by the release of microvesicles. Objective: To investigate the effect of suppressor of cytokine signaling 3 (SOCS3) gene on the proliferation of human glomerular mesangial cells (HMCs) stimulated by aIgA1 from patients with IgA nephropathy (IgAN), and explore whether this effect is mediated through Toll like receptor 4 (TLR4) or Transforming growth factor-b1 (TGF-b1). Methods: Serum monomeric IgA1 was isolated with jacalin affinity and Sephacryl S-200 HR chromatography from IgAN patients, and then heated to aggregated form (aIgA1). HMC was transfected with Adv-SOCS3-IRES2-EGFP for 48 hours, and incubated with aIgA1 subsequently. The cells were divided into blank control group, IgA1 group, IgA1+ Adv-EGFP group and IgA1+ Adv-SOCS3-IRES2-EGFP group. We observed mesangial cell proliferation through MTT, and detected the levels of SOCS3, TLR4, TGF-b1 protein and mRNA through western blotting and Real-time PCR. Results: HMC proliferation was promoted significantly after aIgA1 stimulation, and the strongest effect of promoting cell proliferation was observed at 0.5 mg/ml concentration after 48h stimulation. Comparing IgA1 group with control group, the protein and mRNA expression of SOCS3, TLR4, TGF-b1 were significantly increased in IgA1 group (p < 0.05). Comparing with IgA1 group and IgA1+Adv-EGFP group, MTT absorbency was obviously reduced after incubation with aIgA1 for 24h and 48h in IgA+Adv-SOCS3-EGFP group, and the protein and mRNA expression of TLR4 and TGF-b1 were significantly decreased in IgA1+Adv-SOCS3-EGFP group (p < 0.05).
Conclusion:
The stimulation of aIgA1 from IgAN patients promoted HMC proliferation, also upregulated the expression of SOCS3, TLR4 and TGF-b1 in HMC. Overexpression of SOCS3 may inhibit the proliferation of HMC which stimulated by aIgA1, partly through down-regulating the expression of TLR4 and TGF-b1. Background: The role of transcription factors SRF, which regulate CArG element contained genes, in IgA nephropathy is unknown. Methods: Here we performed expression of SRF in human IgA nephropathy tissues from I to V stage and the cultured proximal tubular cells (HK-2) under hypoxia or induced by TGF-b compared with control conditions. Results: We performed SRF expression from formalin-fixed, paraffin-embedded tissues from renal biopsies diagnosis as IgA nephropathy. We noted the greatest change in SRF expression, which was significantly higher in IgA V stage compared with early presenters, like IgA I or II stage. Furthermore, in individual biopsies, high expression of SRF correlated with tubulointerstitial fibrosis and low estimated GFR. Next, in vitro, we identified overexpression of SRF was observed in hypoxia-induced HK-2 cells. Treatment of HK-2 with TGF-b increased SRF expression. Lower expression of SRF suppressed expression of the CArG element snail1, thereby opposing TGF-b-mediated downregulation of E-cadherin. Conclusion: High expression of SRF associates with increased fibrosis and decreased estimated GFR in IgA nephropathy in vivo, perhaps by Table 1 The feature of the receiver operating characteristic curve of miRNAs for diagnosing IgAN. 
